nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—Theobromine—Pentoxifylline—systemic scleroderma	0.169	0.366	CrCrCtD
Theophylline—Dyphylline—Pentoxifylline—systemic scleroderma	0.146	0.317	CrCrCtD
Theophylline—Caffeine—Pentoxifylline—systemic scleroderma	0.146	0.317	CrCrCtD
Theophylline—PDE5A—Pentoxifylline—systemic scleroderma	0.0883	0.2	CbGbCtD
Theophylline—ADORA2B—Pentoxifylline—systemic scleroderma	0.0883	0.2	CbGbCtD
Theophylline—ADORA1—Pentoxifylline—systemic scleroderma	0.0639	0.144	CbGbCtD
Theophylline—ADORA2A—Pentoxifylline—systemic scleroderma	0.0564	0.128	CbGbCtD
Theophylline—PDE4A—Pentoxifylline—systemic scleroderma	0.0507	0.115	CbGbCtD
Theophylline—PDE4B—Pentoxifylline—systemic scleroderma	0.0483	0.109	CbGbCtD
Theophylline—CYP2C8—Mometasone—systemic scleroderma	0.0115	0.026	CbGbCtD
Theophylline—SLC22A7—Methotrexate—systemic scleroderma	0.00656	0.0148	CbGbCtD
Theophylline—CYP1A2—Pentoxifylline—systemic scleroderma	0.00601	0.0136	CbGbCtD
Theophylline—CYP1A2—Leflunomide—systemic scleroderma	0.00574	0.013	CbGbCtD
Theophylline—CYP2C9—Leflunomide—systemic scleroderma	0.00517	0.0117	CbGbCtD
Theophylline—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00458	0.0103	CbGbCtD
Theophylline—CYP2C9—cardial valve—systemic scleroderma	0.004	0.136	CbGeAlD
Theophylline—PDE5A—pulmonary artery—systemic scleroderma	0.00396	0.135	CbGeAlD
Theophylline—CYP2D6—Captopril—systemic scleroderma	0.00371	0.00838	CbGbCtD
Theophylline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00186	0.0042	CbGbCtD
Theophylline—HDAC2—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.00153	1	CbGdCrCtD
Theophylline—CYP3A4—Prednisone—systemic scleroderma	0.00148	0.00335	CbGbCtD
Theophylline—PDE5A—artery—systemic scleroderma	0.00147	0.0499	CbGeAlD
Theophylline—PDE5A—endothelium—systemic scleroderma	0.00124	0.0421	CbGeAlD
Theophylline—PDE5A—blood vessel—systemic scleroderma	0.00114	0.0388	CbGeAlD
Theophylline—PDE3B—connective tissue—systemic scleroderma	0.000933	0.0317	CbGeAlD
Theophylline—ADORA2B—smooth muscle tissue—systemic scleroderma	0.000707	0.024	CbGeAlD
Theophylline—ADA—connective tissue—systemic scleroderma	0.000707	0.024	CbGeAlD
Theophylline—PDE5A—connective tissue—systemic scleroderma	0.000586	0.0199	CbGeAlD
Theophylline—PDE3B—lung—systemic scleroderma	0.000563	0.0191	CbGeAlD
Theophylline—HDAC2—connective tissue—systemic scleroderma	0.000549	0.0186	CbGeAlD
Theophylline—PDE5A—smooth muscle tissue—systemic scleroderma	0.000536	0.0182	CbGeAlD
Theophylline—PDE4D—tendon—systemic scleroderma	0.000535	0.0182	CbGeAlD
Theophylline—PDE3A—smooth muscle tissue—systemic scleroderma	0.000521	0.0177	CbGeAlD
Theophylline—ADA—digestive system—systemic scleroderma	0.000511	0.0174	CbGeAlD
Theophylline—HDAC2—smooth muscle tissue—systemic scleroderma	0.000502	0.0171	CbGeAlD
Theophylline—HDAC2—skin of body—systemic scleroderma	0.000495	0.0168	CbGeAlD
Theophylline—ADA—tendon—systemic scleroderma	0.000486	0.0165	CbGeAlD
Theophylline—PDE4D—lung—systemic scleroderma	0.00047	0.016	CbGeAlD
Theophylline—ADORA2B—lung—systemic scleroderma	0.000466	0.0159	CbGeAlD
Theophylline—SLC22A7—digestive system—systemic scleroderma	0.000461	0.0157	CbGeAlD
Theophylline—ADA—lung—systemic scleroderma	0.000427	0.0145	CbGeAlD
Theophylline—PDE5A—digestive system—systemic scleroderma	0.000423	0.0144	CbGeAlD
Theophylline—PDE4A—lung—systemic scleroderma	0.000416	0.0141	CbGeAlD
Theophylline—PDE5A—tendon—systemic scleroderma	0.000403	0.0137	CbGeAlD
Theophylline—HDAC2—digestive system—systemic scleroderma	0.000396	0.0135	CbGeAlD
Theophylline—PDE3A—tendon—systemic scleroderma	0.000392	0.0133	CbGeAlD
Theophylline—ADORA1—tendon—systemic scleroderma	0.000382	0.013	CbGeAlD
Theophylline—HDAC2—tendon—systemic scleroderma	0.000377	0.0128	CbGeAlD
Theophylline—PDE5A—lung—systemic scleroderma	0.000353	0.012	CbGeAlD
Theophylline—CYP1B1—connective tissue—systemic scleroderma	0.000352	0.012	CbGeAlD
Theophylline—PDE3A—lung—systemic scleroderma	0.000344	0.0117	CbGeAlD
Theophylline—ADORA1—lung—systemic scleroderma	0.000335	0.0114	CbGeAlD
Theophylline—HDAC2—lung—systemic scleroderma	0.000331	0.0112	CbGeAlD
Theophylline—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000322	0.0109	CbGeAlD
Theophylline—CYP1B1—skin of body—systemic scleroderma	0.000318	0.0108	CbGeAlD
Theophylline—PDE4B—tendon—systemic scleroderma	0.000282	0.0096	CbGeAlD
Theophylline—CYP1B1—digestive system—systemic scleroderma	0.000254	0.00864	CbGeAlD
Theophylline—PDE4B—lung—systemic scleroderma	0.000248	0.00842	CbGeAlD
Theophylline—CYP1B1—tendon—systemic scleroderma	0.000242	0.00823	CbGeAlD
Theophylline—CYP1A1—skin of body—systemic scleroderma	0.000225	0.00764	CbGeAlD
Theophylline—CYP1B1—lung—systemic scleroderma	0.000212	0.00722	CbGeAlD
Theophylline—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000206	0.00337	CcSEcCtD
Theophylline—Alopecia—Captopril—systemic scleroderma	0.000206	0.00336	CcSEcCtD
Theophylline—Hypotension—Pentoxifylline—systemic scleroderma	0.000204	0.00333	CcSEcCtD
Theophylline—Haematuria—Leflunomide—systemic scleroderma	0.000204	0.00333	CcSEcCtD
Theophylline—Tension—Captopril—systemic scleroderma	0.000199	0.00325	CcSEcCtD
Theophylline—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00325	CcSEcCtD
Theophylline—Insomnia—Pentoxifylline—systemic scleroderma	0.000197	0.00323	CcSEcCtD
Theophylline—Nervousness—Captopril—systemic scleroderma	0.000197	0.00322	CcSEcCtD
Theophylline—Haematuria—Mycophenolic acid—systemic scleroderma	0.000194	0.00318	CcSEcCtD
Theophylline—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00019	0.00311	CcSEcCtD
Theophylline—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00019	0.0031	CcSEcCtD
Theophylline—Anaphylactic shock—Mometasone—systemic scleroderma	0.000188	0.00308	CcSEcCtD
Theophylline—Infection—Mometasone—systemic scleroderma	0.000187	0.00306	CcSEcCtD
Theophylline—Extravasation—Methotrexate—systemic scleroderma	0.000187	0.00305	CcSEcCtD
Theophylline—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000186	0.00304	CcSEcCtD
Theophylline—CYP1A2—digestive system—systemic scleroderma	0.000182	0.0062	CbGeAlD
Theophylline—Arrhythmia—Azathioprine—systemic scleroderma	0.000182	0.00297	CcSEcCtD
Theophylline—CYP1A1—digestive system—systemic scleroderma	0.00018	0.00611	CbGeAlD
Theophylline—Alopecia—Azathioprine—systemic scleroderma	0.00018	0.00294	CcSEcCtD
Theophylline—Anorexia—Mometasone—systemic scleroderma	0.00018	0.00294	CcSEcCtD
Theophylline—Palpitations—Captopril—systemic scleroderma	0.000179	0.00293	CcSEcCtD
Theophylline—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000179	0.00292	CcSEcCtD
Theophylline—Hyperuricaemia—Methotrexate—systemic scleroderma	0.000176	0.00287	CcSEcCtD
Theophylline—Haematuria—Lisinopril—systemic scleroderma	0.000175	0.00286	CcSEcCtD
Theophylline—Urticaria—Pentoxifylline—systemic scleroderma	0.000173	0.00284	CcSEcCtD
Theophylline—CYP2C9—digestive system—systemic scleroderma	0.000173	0.00588	CbGeAlD
Theophylline—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000173	0.00282	CcSEcCtD
Theophylline—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000173	0.00282	CcSEcCtD
Theophylline—Arrhythmia—Leflunomide—systemic scleroderma	0.000171	0.0028	CcSEcCtD
Theophylline—Alopecia—Leflunomide—systemic scleroderma	0.00017	0.00277	CcSEcCtD
Theophylline—Blood uric acid increased—Methotrexate—systemic scleroderma	0.000166	0.00271	CcSEcCtD
Theophylline—Anaphylactic shock—Captopril—systemic scleroderma	0.000165	0.0027	CcSEcCtD
Theophylline—CYP2E1—digestive system—systemic scleroderma	0.000164	0.00557	CbGeAlD
Theophylline—Decreased appetite—Mometasone—systemic scleroderma	0.000164	0.00268	CcSEcCtD
Theophylline—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000164	0.00267	CcSEcCtD
Theophylline—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00266	CcSEcCtD
Theophylline—Shock—Captopril—systemic scleroderma	0.000163	0.00266	CcSEcCtD
Theophylline—Alopecia—Mycophenolic acid—systemic scleroderma	0.000162	0.00264	CcSEcCtD
Theophylline—Tachycardia—Captopril—systemic scleroderma	0.000161	0.00264	CcSEcCtD
Theophylline—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000161	0.00263	CcSEcCtD
Theophylline—Anorexia—Captopril—systemic scleroderma	0.000158	0.00258	CcSEcCtD
Theophylline—Tension—Mycophenolic acid—systemic scleroderma	0.000156	0.00256	CcSEcCtD
Theophylline—CYP2E1—tendon—systemic scleroderma	0.000156	0.0053	CbGeAlD
Theophylline—Nervousness—Mycophenolic acid—systemic scleroderma	0.000155	0.00253	CcSEcCtD
Theophylline—Hypotension—Captopril—systemic scleroderma	0.000155	0.00253	CcSEcCtD
Theophylline—Pruritus—Pentoxifylline—systemic scleroderma	0.000154	0.00252	CcSEcCtD
Theophylline—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000154	0.00252	CcSEcCtD
Theophylline—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000153	0.00251	CcSEcCtD
Theophylline—Flushing—Lisinopril—systemic scleroderma	0.000153	0.0025	CcSEcCtD
Theophylline—CYP1A2—lung—systemic scleroderma	0.000152	0.00517	CbGeAlD
Theophylline—CYP1A1—lung—systemic scleroderma	0.00015	0.0051	CbGeAlD
Theophylline—Insomnia—Captopril—systemic scleroderma	0.00015	0.00245	CcSEcCtD
Theophylline—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000149	0.00244	CcSEcCtD
Theophylline—Tremor—Mycophenolic acid—systemic scleroderma	0.000149	0.00244	CcSEcCtD
Theophylline—Coma—Methotrexate—systemic scleroderma	0.000149	0.00243	CcSEcCtD
Theophylline—Abdominal pain—Mometasone—systemic scleroderma	0.000149	0.00243	CcSEcCtD
Theophylline—Body temperature increased—Mometasone—systemic scleroderma	0.000149	0.00243	CcSEcCtD
Theophylline—Palpitations—Leflunomide—systemic scleroderma	0.000148	0.00241	CcSEcCtD
Theophylline—Arrhythmia—Lisinopril—systemic scleroderma	0.000147	0.00241	CcSEcCtD
Theophylline—Agitation—Mycophenolic acid—systemic scleroderma	0.000146	0.00239	CcSEcCtD
Theophylline—Alopecia—Lisinopril—systemic scleroderma	0.000146	0.00238	CcSEcCtD
Theophylline—Dizziness—Pentoxifylline—systemic scleroderma	0.000144	0.00236	CcSEcCtD
Theophylline—Decreased appetite—Captopril—systemic scleroderma	0.000144	0.00235	CcSEcCtD
Theophylline—Infection—Azathioprine—systemic scleroderma	0.000143	0.00235	CcSEcCtD
Theophylline—Anxiety—Leflunomide—systemic scleroderma	0.000142	0.00232	CcSEcCtD
Theophylline—Tension—Lisinopril—systemic scleroderma	0.000141	0.0023	CcSEcCtD
Theophylline—Palpitations—Mycophenolic acid—systemic scleroderma	0.000141	0.0023	CcSEcCtD
Theophylline—Nervousness—Lisinopril—systemic scleroderma	0.000139	0.00228	CcSEcCtD
Theophylline—Vomiting—Pentoxifylline—systemic scleroderma	0.000139	0.00227	CcSEcCtD
Theophylline—Convulsion—Mycophenolic acid—systemic scleroderma	0.000138	0.00226	CcSEcCtD
Theophylline—Rash—Pentoxifylline—systemic scleroderma	0.000138	0.00225	CcSEcCtD
Theophylline—Dermatitis—Pentoxifylline—systemic scleroderma	0.000138	0.00225	CcSEcCtD
Theophylline—CYP2E1—lung—systemic scleroderma	0.000137	0.00465	CbGeAlD
Theophylline—Headache—Pentoxifylline—systemic scleroderma	0.000137	0.00224	CcSEcCtD
Theophylline—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000136	0.00223	CcSEcCtD
Theophylline—Infection—Leflunomide—systemic scleroderma	0.000135	0.00221	CcSEcCtD
Theophylline—Gastrointestinal pain—Captopril—systemic scleroderma	0.000135	0.00221	CcSEcCtD
Theophylline—Anxiety—Mycophenolic acid—systemic scleroderma	0.000135	0.00221	CcSEcCtD
Theophylline—Irritability—Prednisone—systemic scleroderma	0.000135	0.00221	CcSEcCtD
Theophylline—Hypotension—Azathioprine—systemic scleroderma	0.000135	0.00221	CcSEcCtD
Theophylline—Polyuria—Methotrexate—systemic scleroderma	0.000135	0.0022	CcSEcCtD
Theophylline—Tremor—Lisinopril—systemic scleroderma	0.000134	0.0022	CcSEcCtD
Theophylline—Nervous system disorder—Leflunomide—systemic scleroderma	0.000134	0.00219	CcSEcCtD
Theophylline—Pruritus—Mometasone—systemic scleroderma	0.000133	0.00218	CcSEcCtD
Theophylline—Tachycardia—Leflunomide—systemic scleroderma	0.000133	0.00218	CcSEcCtD
Theophylline—CYP3A4—digestive system—systemic scleroderma	0.000132	0.00448	CbGeAlD
Theophylline—Body temperature increased—Captopril—systemic scleroderma	0.000131	0.00214	CcSEcCtD
Theophylline—Abdominal pain—Captopril—systemic scleroderma	0.000131	0.00214	CcSEcCtD
Theophylline—Anorexia—Leflunomide—systemic scleroderma	0.00013	0.00212	CcSEcCtD
Theophylline—CYP2D6—digestive system—systemic scleroderma	0.00013	0.00441	CbGeAlD
Theophylline—Nausea—Pentoxifylline—systemic scleroderma	0.00013	0.00212	CcSEcCtD
Theophylline—Infection—Mycophenolic acid—systemic scleroderma	0.000129	0.00211	CcSEcCtD
Theophylline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00211	CcSEcCtD
Theophylline—Diarrhoea—Mometasone—systemic scleroderma	0.000129	0.00211	CcSEcCtD
Theophylline—Hypokalaemia—Prednisone—systemic scleroderma	0.000129	0.00211	CcSEcCtD
Theophylline—Shock—Mycophenolic acid—systemic scleroderma	0.000128	0.00209	CcSEcCtD
Theophylline—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000128	0.00209	CcSEcCtD
Theophylline—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000128	0.00209	CcSEcCtD
Theophylline—Hypotension—Leflunomide—systemic scleroderma	0.000127	0.00208	CcSEcCtD
Theophylline—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000127	0.00208	CcSEcCtD
Theophylline—Palpitations—Lisinopril—systemic scleroderma	0.000127	0.00207	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000125	0.00205	CcSEcCtD
Theophylline—Anorexia—Mycophenolic acid—systemic scleroderma	0.000124	0.00203	CcSEcCtD
Theophylline—Tension—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00202	CcSEcCtD
Theophylline—Insomnia—Leflunomide—systemic scleroderma	0.000123	0.00202	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000122	0.002	CcSEcCtD
Theophylline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000122	0.002	CcSEcCtD
Theophylline—Anxiety—Lisinopril—systemic scleroderma	0.000122	0.00199	CcSEcCtD
Theophylline—Hypotension—Mycophenolic acid—systemic scleroderma	0.000122	0.00199	CcSEcCtD
Theophylline—Vomiting—Mometasone—systemic scleroderma	0.00012	0.00196	CcSEcCtD
Theophylline—Rash—Mometasone—systemic scleroderma	0.000119	0.00194	CcSEcCtD
Theophylline—Dermatitis—Mometasone—systemic scleroderma	0.000119	0.00194	CcSEcCtD
Theophylline—Decreased appetite—Leflunomide—systemic scleroderma	0.000119	0.00194	CcSEcCtD
Theophylline—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000118	0.00193	CcSEcCtD
Theophylline—Headache—Mometasone—systemic scleroderma	0.000118	0.00193	CcSEcCtD
Theophylline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00193	CcSEcCtD
Theophylline—Insomnia—Mycophenolic acid—systemic scleroderma	0.000118	0.00192	CcSEcCtD
Theophylline—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000117	0.00192	CcSEcCtD
Theophylline—Pruritus—Captopril—systemic scleroderma	0.000117	0.00191	CcSEcCtD
Theophylline—Infection—Lisinopril—systemic scleroderma	0.000116	0.0019	CcSEcCtD
Theophylline—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000116	0.00189	CcSEcCtD
Theophylline—Shock—Lisinopril—systemic scleroderma	0.000115	0.00188	CcSEcCtD
Theophylline—Tachycardia—Lisinopril—systemic scleroderma	0.000114	0.00187	CcSEcCtD
Theophylline—Abdominal pain—Azathioprine—systemic scleroderma	0.000114	0.00187	CcSEcCtD
Theophylline—Body temperature increased—Azathioprine—systemic scleroderma	0.000114	0.00187	CcSEcCtD
Theophylline—Diarrhoea—Captopril—systemic scleroderma	0.000113	0.00185	CcSEcCtD
Theophylline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000113	0.00185	CcSEcCtD
Theophylline—Irritability—Methotrexate—systemic scleroderma	0.000113	0.00185	CcSEcCtD
Theophylline—Nausea—Mometasone—systemic scleroderma	0.000112	0.00183	CcSEcCtD
Theophylline—Anorexia—Lisinopril—systemic scleroderma	0.000112	0.00183	CcSEcCtD
Theophylline—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000111	0.00182	CcSEcCtD
Theophylline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00182	CcSEcCtD
Theophylline—Hyperglycaemia—Prednisone—systemic scleroderma	0.00011	0.0018	CcSEcCtD
Theophylline—Hypotension—Lisinopril—systemic scleroderma	0.000109	0.00179	CcSEcCtD
Theophylline—Dizziness—Captopril—systemic scleroderma	0.000109	0.00179	CcSEcCtD
Theophylline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00178	CcSEcCtD
Theophylline—Urticaria—Leflunomide—systemic scleroderma	0.000108	0.00177	CcSEcCtD
Theophylline—Body temperature increased—Leflunomide—systemic scleroderma	0.000108	0.00176	CcSEcCtD
Theophylline—Abdominal pain—Leflunomide—systemic scleroderma	0.000108	0.00176	CcSEcCtD
Theophylline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000107	0.00174	CcSEcCtD
Theophylline—Hypersensitivity—Azathioprine—systemic scleroderma	0.000106	0.00174	CcSEcCtD
Theophylline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000106	0.00174	CcSEcCtD
Theophylline—Insomnia—Lisinopril—systemic scleroderma	0.000106	0.00173	CcSEcCtD
Theophylline—Vomiting—Captopril—systemic scleroderma	0.000105	0.00172	CcSEcCtD
Theophylline—Rash—Captopril—systemic scleroderma	0.000104	0.00171	CcSEcCtD
Theophylline—Dermatitis—Captopril—systemic scleroderma	0.000104	0.0017	CcSEcCtD
Theophylline—Headache—Captopril—systemic scleroderma	0.000104	0.00169	CcSEcCtD
Theophylline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000103	0.00168	CcSEcCtD
Theophylline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000103	0.00168	CcSEcCtD
Theophylline—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000103	0.00168	CcSEcCtD
Theophylline—Infection—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00167	CcSEcCtD
Theophylline—Decreased appetite—Lisinopril—systemic scleroderma	0.000102	0.00167	CcSEcCtD
Theophylline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00165	CcSEcCtD
Theophylline—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00165	CcSEcCtD
Theophylline—Hypersensitivity—Leflunomide—systemic scleroderma	0.0001	0.00164	CcSEcCtD
Theophylline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00164	CcSEcCtD
Theophylline—Diarrhoea—Azathioprine—systemic scleroderma	9.88e-05	0.00162	CcSEcCtD
Theophylline—Nausea—Captopril—systemic scleroderma	9.83e-05	0.00161	CcSEcCtD
Theophylline—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.79e-05	0.0016	CcSEcCtD
Theophylline—Pruritus—Leflunomide—systemic scleroderma	9.65e-05	0.00158	CcSEcCtD
Theophylline—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.59e-05	0.00157	CcSEcCtD
Theophylline—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.58e-05	0.00157	CcSEcCtD
Theophylline—Dizziness—Azathioprine—systemic scleroderma	9.55e-05	0.00156	CcSEcCtD
Theophylline—Diarrhoea—Leflunomide—systemic scleroderma	9.33e-05	0.00153	CcSEcCtD
Theophylline—Urticaria—Lisinopril—systemic scleroderma	9.31e-05	0.00152	CcSEcCtD
Theophylline—Insomnia—Mycophenolate mofetil—systemic scleroderma	9.28e-05	0.00152	CcSEcCtD
Theophylline—Body temperature increased—Lisinopril—systemic scleroderma	9.26e-05	0.00151	CcSEcCtD
Theophylline—Abdominal pain—Lisinopril—systemic scleroderma	9.26e-05	0.00151	CcSEcCtD
Theophylline—Pruritus—Mycophenolic acid—systemic scleroderma	9.2e-05	0.0015	CcSEcCtD
Theophylline—Vomiting—Azathioprine—systemic scleroderma	9.18e-05	0.0015	CcSEcCtD
Theophylline—Rash—Azathioprine—systemic scleroderma	9.1e-05	0.00149	CcSEcCtD
Theophylline—Dermatitis—Azathioprine—systemic scleroderma	9.1e-05	0.00149	CcSEcCtD
Theophylline—Flushing—Prednisone—systemic scleroderma	9.09e-05	0.00149	CcSEcCtD
Theophylline—Headache—Azathioprine—systemic scleroderma	9.05e-05	0.00148	CcSEcCtD
Theophylline—Dizziness—Leflunomide—systemic scleroderma	9.02e-05	0.00147	CcSEcCtD
Theophylline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.92e-05	0.00146	CcSEcCtD
Theophylline—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.9e-05	0.00145	CcSEcCtD
Theophylline—Arrhythmia—Prednisone—systemic scleroderma	8.75e-05	0.00143	CcSEcCtD
Theophylline—Haematuria—Methotrexate—systemic scleroderma	8.69e-05	0.00142	CcSEcCtD
Theophylline—Vomiting—Leflunomide—systemic scleroderma	8.67e-05	0.00142	CcSEcCtD
Theophylline—Alopecia—Prednisone—systemic scleroderma	8.65e-05	0.00141	CcSEcCtD
Theophylline—Hypersensitivity—Lisinopril—systemic scleroderma	8.63e-05	0.00141	CcSEcCtD
Theophylline—Dizziness—Mycophenolic acid—systemic scleroderma	8.6e-05	0.00141	CcSEcCtD
Theophylline—Rash—Leflunomide—systemic scleroderma	8.6e-05	0.00141	CcSEcCtD
Theophylline—Dermatitis—Leflunomide—systemic scleroderma	8.59e-05	0.0014	CcSEcCtD
Theophylline—Nausea—Azathioprine—systemic scleroderma	8.58e-05	0.0014	CcSEcCtD
Theophylline—Headache—Leflunomide—systemic scleroderma	8.54e-05	0.0014	CcSEcCtD
Theophylline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.39e-05	0.00137	CcSEcCtD
Theophylline—Pruritus—Lisinopril—systemic scleroderma	8.29e-05	0.00136	CcSEcCtD
Theophylline—Vomiting—Mycophenolic acid—systemic scleroderma	8.27e-05	0.00135	CcSEcCtD
Theophylline—Rash—Mycophenolic acid—systemic scleroderma	8.2e-05	0.00134	CcSEcCtD
Theophylline—Dermatitis—Mycophenolic acid—systemic scleroderma	8.19e-05	0.00134	CcSEcCtD
Theophylline—Urticaria—Mycophenolate mofetil—systemic scleroderma	8.16e-05	0.00133	CcSEcCtD
Theophylline—Headache—Mycophenolic acid—systemic scleroderma	8.15e-05	0.00133	CcSEcCtD
Theophylline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	8.12e-05	0.00133	CcSEcCtD
Theophylline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	8.12e-05	0.00133	CcSEcCtD
Theophylline—Nausea—Leflunomide—systemic scleroderma	8.1e-05	0.00132	CcSEcCtD
Theophylline—Diarrhoea—Lisinopril—systemic scleroderma	8.02e-05	0.00131	CcSEcCtD
Theophylline—Agitation—Prednisone—systemic scleroderma	7.84e-05	0.00128	CcSEcCtD
Theophylline—Dizziness—Lisinopril—systemic scleroderma	7.75e-05	0.00127	CcSEcCtD
Theophylline—Nausea—Mycophenolic acid—systemic scleroderma	7.73e-05	0.00126	CcSEcCtD
Theophylline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.56e-05	0.00124	CcSEcCtD
Theophylline—Vomiting—Lisinopril—systemic scleroderma	7.45e-05	0.00122	CcSEcCtD
Theophylline—Rash—Lisinopril—systemic scleroderma	7.39e-05	0.00121	CcSEcCtD
Theophylline—Convulsion—Prednisone—systemic scleroderma	7.39e-05	0.00121	CcSEcCtD
Theophylline—Dermatitis—Lisinopril—systemic scleroderma	7.38e-05	0.00121	CcSEcCtD
Theophylline—Headache—Lisinopril—systemic scleroderma	7.34e-05	0.0012	CcSEcCtD
Theophylline—Pruritus—Mycophenolate mofetil—systemic scleroderma	7.26e-05	0.00119	CcSEcCtD
Theophylline—Anxiety—Prednisone—systemic scleroderma	7.23e-05	0.00118	CcSEcCtD
Theophylline—Alopecia—Methotrexate—systemic scleroderma	7.23e-05	0.00118	CcSEcCtD
Theophylline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	7.02e-05	0.00115	CcSEcCtD
Theophylline—Nausea—Lisinopril—systemic scleroderma	6.96e-05	0.00114	CcSEcCtD
Theophylline—Anaphylactic shock—Prednisone—systemic scleroderma	6.96e-05	0.00114	CcSEcCtD
Theophylline—Infection—Prednisone—systemic scleroderma	6.91e-05	0.00113	CcSEcCtD
Theophylline—Shock—Prednisone—systemic scleroderma	6.85e-05	0.00112	CcSEcCtD
Theophylline—Nervous system disorder—Prednisone—systemic scleroderma	6.82e-05	0.00112	CcSEcCtD
Theophylline—Tachycardia—Prednisone—systemic scleroderma	6.79e-05	0.00111	CcSEcCtD
Theophylline—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.79e-05	0.00111	CcSEcCtD
Theophylline—Anorexia—Prednisone—systemic scleroderma	6.63e-05	0.00108	CcSEcCtD
Theophylline—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.53e-05	0.00107	CcSEcCtD
Theophylline—Rash—Mycophenolate mofetil—systemic scleroderma	6.47e-05	0.00106	CcSEcCtD
Theophylline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.47e-05	0.00106	CcSEcCtD
Theophylline—Headache—Mycophenolate mofetil—systemic scleroderma	6.43e-05	0.00105	CcSEcCtD
Theophylline—Insomnia—Prednisone—systemic scleroderma	6.29e-05	0.00103	CcSEcCtD
Theophylline—Convulsion—Methotrexate—systemic scleroderma	6.17e-05	0.00101	CcSEcCtD
Theophylline—Nausea—Mycophenolate mofetil—systemic scleroderma	6.1e-05	0.000997	CcSEcCtD
Theophylline—Decreased appetite—Prednisone—systemic scleroderma	6.05e-05	0.000989	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—systemic scleroderma	5.82e-05	0.000951	CcSEcCtD
Theophylline—Infection—Methotrexate—systemic scleroderma	5.78e-05	0.000944	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—systemic scleroderma	5.7e-05	0.000932	CcSEcCtD
Theophylline—Gastrointestinal pain—Prednisone—systemic scleroderma	5.69e-05	0.00093	CcSEcCtD
Theophylline—Anorexia—Methotrexate—systemic scleroderma	5.54e-05	0.000906	CcSEcCtD
Theophylline—Urticaria—Prednisone—systemic scleroderma	5.53e-05	0.000904	CcSEcCtD
Theophylline—Abdominal pain—Prednisone—systemic scleroderma	5.5e-05	0.000899	CcSEcCtD
Theophylline—Body temperature increased—Prednisone—systemic scleroderma	5.5e-05	0.000899	CcSEcCtD
Theophylline—Hypotension—Methotrexate—systemic scleroderma	5.43e-05	0.000888	CcSEcCtD
Theophylline—Insomnia—Methotrexate—systemic scleroderma	5.26e-05	0.00086	CcSEcCtD
Theophylline—Hypersensitivity—Prednisone—systemic scleroderma	5.13e-05	0.000838	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—systemic scleroderma	5.06e-05	0.000826	CcSEcCtD
Theophylline—Pruritus—Prednisone—systemic scleroderma	4.92e-05	0.000805	CcSEcCtD
Theophylline—Diarrhoea—Prednisone—systemic scleroderma	4.76e-05	0.000778	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.76e-05	0.000777	CcSEcCtD
Theophylline—Urticaria—Methotrexate—systemic scleroderma	4.62e-05	0.000755	CcSEcCtD
Theophylline—Dizziness—Prednisone—systemic scleroderma	4.6e-05	0.000752	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—systemic scleroderma	4.6e-05	0.000752	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—systemic scleroderma	4.6e-05	0.000752	CcSEcCtD
Theophylline—Vomiting—Prednisone—systemic scleroderma	4.42e-05	0.000723	CcSEcCtD
Theophylline—Rash—Prednisone—systemic scleroderma	4.39e-05	0.000717	CcSEcCtD
Theophylline—Dermatitis—Prednisone—systemic scleroderma	4.38e-05	0.000717	CcSEcCtD
Theophylline—Headache—Prednisone—systemic scleroderma	4.36e-05	0.000713	CcSEcCtD
Theophylline—HDAC2—Direct p53 effectors—IRF5—systemic scleroderma	4.35e-05	0.0106	CbGpPWpGaD
Theophylline—Hypersensitivity—Methotrexate—systemic scleroderma	4.28e-05	0.0007	CcSEcCtD
Theophylline—Nausea—Prednisone—systemic scleroderma	4.13e-05	0.000676	CcSEcCtD
Theophylline—Pruritus—Methotrexate—systemic scleroderma	4.11e-05	0.000673	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—systemic scleroderma	3.98e-05	0.00065	CcSEcCtD
Theophylline—PDE5A—Hemostasis—SELP—systemic scleroderma	3.95e-05	0.00965	CbGpPWpGaD
Theophylline—ADORA2A—Monoamine Transport—IL1B—systemic scleroderma	3.89e-05	0.00951	CbGpPWpGaD
Theophylline—Dizziness—Methotrexate—systemic scleroderma	3.85e-05	0.000629	CcSEcCtD
Theophylline—Vomiting—Methotrexate—systemic scleroderma	3.7e-05	0.000604	CcSEcCtD
Theophylline—PDE5A—Hemostasis—RHOB—systemic scleroderma	3.69e-05	0.00901	CbGpPWpGaD
Theophylline—Rash—Methotrexate—systemic scleroderma	3.67e-05	0.000599	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—systemic scleroderma	3.66e-05	0.000599	CcSEcCtD
Theophylline—Headache—Methotrexate—systemic scleroderma	3.64e-05	0.000596	CcSEcCtD
Theophylline—CYP1A1—Melatonin metabolism and effects—EDN1—systemic scleroderma	3.54e-05	0.00864	CbGpPWpGaD
Theophylline—Nausea—Methotrexate—systemic scleroderma	3.45e-05	0.000565	CcSEcCtD
Theophylline—PDE3B—Leptin signaling pathway—NOS3—systemic scleroderma	3.42e-05	0.00835	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—CSK—systemic scleroderma	3.36e-05	0.0082	CbGpPWpGaD
Theophylline—PDE3B—Platelet homeostasis—NOS3—systemic scleroderma	3.31e-05	0.00809	CbGpPWpGaD
Theophylline—HDAC2—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	3.2e-05	0.00781	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—ITGAM—systemic scleroderma	3.16e-05	0.00771	CbGpPWpGaD
Theophylline—PDE3A—Platelet homeostasis—NOS3—systemic scleroderma	3.02e-05	0.00737	CbGpPWpGaD
Theophylline—PDE3B—Leptin signaling pathway—IL1B—systemic scleroderma	2.91e-05	0.00711	CbGpPWpGaD
Theophylline—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	2.66e-05	0.0065	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—SELP—systemic scleroderma	2.56e-05	0.00624	CbGpPWpGaD
Theophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	2.52e-05	0.00616	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—RHOB—systemic scleroderma	2.39e-05	0.00583	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—SELP—systemic scleroderma	2.33e-05	0.00569	CbGpPWpGaD
Theophylline—CYP1A2—Melatonin metabolism and effects—EDN1—systemic scleroderma	2.25e-05	0.00551	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—CSK—systemic scleroderma	2.17e-05	0.00531	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—RHOB—systemic scleroderma	2.17e-05	0.00531	CbGpPWpGaD
Theophylline—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	2.06e-05	0.00503	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—ITGAM—systemic scleroderma	2.04e-05	0.00499	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—CSK—systemic scleroderma	1.98e-05	0.00484	CbGpPWpGaD
Theophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	1.9e-05	0.00463	CbGpPWpGaD
Theophylline—PDE4D—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	1.88e-05	0.0046	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—SELP—systemic scleroderma	1.86e-05	0.00455	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—ITGAM—systemic scleroderma	1.86e-05	0.00455	CbGpPWpGaD
Theophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	1.84e-05	0.00451	CbGpPWpGaD
Theophylline—HDAC2—Regulation of Telomerase—TGFB1—systemic scleroderma	1.78e-05	0.00435	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—RHOB—systemic scleroderma	1.74e-05	0.00424	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—RHOB—systemic scleroderma	1.7e-05	0.00416	CbGpPWpGaD
Theophylline—CYP1A1—PPARA activates gene expression—CTGF—systemic scleroderma	1.7e-05	0.00416	CbGpPWpGaD
Theophylline—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—systemic scleroderma	1.67e-05	0.00407	CbGpPWpGaD
Theophylline—PDE4B—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	1.66e-05	0.00405	CbGpPWpGaD
Theophylline—HDAC2—Direct p53 effectors—MMP2—systemic scleroderma	1.61e-05	0.00394	CbGpPWpGaD
Theophylline—PDE4D—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	1.6e-05	0.00391	CbGpPWpGaD
Theophylline—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	1.6e-05	0.00391	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—MMP1—systemic scleroderma	1.58e-05	0.00387	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—CSK—systemic scleroderma	1.58e-05	0.00387	CbGpPWpGaD
Theophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	1.57e-05	0.00383	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—RHOB—systemic scleroderma	1.55e-05	0.0038	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—RHOB—systemic scleroderma	1.55e-05	0.00378	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—RHOB—systemic scleroderma	1.51e-05	0.00368	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—ITGAM—systemic scleroderma	1.49e-05	0.00363	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—RHOB—systemic scleroderma	1.48e-05	0.00362	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—RHOB—systemic scleroderma	1.41e-05	0.00345	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—RHOB—systemic scleroderma	1.41e-05	0.00345	CbGpPWpGaD
Theophylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	1.41e-05	0.00344	CbGpPWpGaD
Theophylline—ADORA2B—GPCR ligand binding—EDN1—systemic scleroderma	1.4e-05	0.00343	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—RHOB—systemic scleroderma	1.37e-05	0.00336	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—RHOB—systemic scleroderma	1.37e-05	0.00335	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—RHOB—systemic scleroderma	1.35e-05	0.00329	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—RHOB—systemic scleroderma	1.32e-05	0.00323	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—RHOB—systemic scleroderma	1.31e-05	0.00319	CbGpPWpGaD
Theophylline—HDAC2—Cell Cycle—TGFB1—systemic scleroderma	1.29e-05	0.00314	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—RHOB—systemic scleroderma	1.28e-05	0.00313	CbGpPWpGaD
Theophylline—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	1.27e-05	0.0031	CbGpPWpGaD
Theophylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.26e-05	0.00308	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—RHOB—systemic scleroderma	1.25e-05	0.00305	CbGpPWpGaD
Theophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	1.21e-05	0.00296	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—RHOB—systemic scleroderma	1.2e-05	0.00293	CbGpPWpGaD
Theophylline—ADORA1—GPCR ligand binding—EDN1—systemic scleroderma	1.19e-05	0.00292	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—RHOB—systemic scleroderma	1.19e-05	0.0029	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—SMAD7—systemic scleroderma	1.18e-05	0.00289	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—SMAD7—systemic scleroderma	1.17e-05	0.00286	CbGpPWpGaD
Theophylline—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	1.15e-05	0.00281	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—NOS3—systemic scleroderma	1.15e-05	0.0028	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—TNFSF13—systemic scleroderma	1.09e-05	0.00266	CbGpPWpGaD
Theophylline—HDAC2—Disease—SMAD7—systemic scleroderma	1.09e-05	0.00266	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—SMAD7—systemic scleroderma	1.08e-05	0.00263	CbGpPWpGaD
Theophylline—ADA—Metabolism—HSPG2—systemic scleroderma	1.08e-05	0.00263	CbGpPWpGaD
Theophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	1.07e-05	0.00262	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—SMAD7—systemic scleroderma	1.05e-05	0.00255	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SMAD7—systemic scleroderma	1.03e-05	0.00251	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—MMP1—systemic scleroderma	1.02e-05	0.0025	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—RHOB—systemic scleroderma	1.02e-05	0.00249	CbGpPWpGaD
Theophylline—HDAC2—Disease—TGFBI—systemic scleroderma	9.94e-06	0.00243	CbGpPWpGaD
Theophylline—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	9.85e-06	0.00241	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	9.8e-06	0.00239	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SMAD7—systemic scleroderma	9.79e-06	0.00239	CbGpPWpGaD
Theophylline—ADORA2B—GPCR ligand binding—CCL2—systemic scleroderma	9.6e-06	0.00235	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SMAD7—systemic scleroderma	9.52e-06	0.00233	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—MMP1—systemic scleroderma	9.32e-06	0.00228	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—RHOB—systemic scleroderma	9.27e-06	0.00226	CbGpPWpGaD
Theophylline—ADORA2A—GPCR ligand binding—EDN1—systemic scleroderma	9.22e-06	0.00225	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SMAD7—systemic scleroderma	9.17e-06	0.00224	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—RHOB—systemic scleroderma	9.14e-06	0.00223	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SMAD7—systemic scleroderma	9.06e-06	0.00221	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—EDN1—systemic scleroderma	8.7e-06	0.00213	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HSPG2—systemic scleroderma	8.62e-06	0.00211	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—RHOB—systemic scleroderma	8.34e-06	0.00204	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CSK—systemic scleroderma	8.32e-06	0.00203	CbGpPWpGaD
Theophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	8.28e-06	0.00202	CbGpPWpGaD
Theophylline—ADORA1—GPCR ligand binding—CCL2—systemic scleroderma	8.16e-06	0.00199	CbGpPWpGaD
Theophylline—ADA—Metabolism—CTGF—systemic scleroderma	8.15e-06	0.00199	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—RHOB—systemic scleroderma	8.09e-06	0.00198	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	8.08e-06	0.00197	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—RHOB—systemic scleroderma	7.96e-06	0.00194	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—EDN1—systemic scleroderma	7.94e-06	0.00194	CbGpPWpGaD
Theophylline—HDAC2—Disease—HSPG2—systemic scleroderma	7.93e-06	0.00194	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—EDN1—systemic scleroderma	7.9e-06	0.00193	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HSPG2—systemic scleroderma	7.86e-06	0.00192	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—EDN1—systemic scleroderma	7.7e-06	0.00188	CbGpPWpGaD
Theophylline—HDAC2—Disease—CSK—systemic scleroderma	7.66e-06	0.00187	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HSPG2—systemic scleroderma	7.63e-06	0.00186	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SMAD7—systemic scleroderma	7.61e-06	0.00186	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CSK—systemic scleroderma	7.6e-06	0.00186	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—TGFB1—systemic scleroderma	7.58e-06	0.00185	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—RHOB—systemic scleroderma	7.57e-06	0.00185	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—EDN1—systemic scleroderma	7.57e-06	0.00185	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HSPG2—systemic scleroderma	7.5e-06	0.00183	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—MMP1—systemic scleroderma	7.45e-06	0.00182	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.43e-06	0.00181	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—NOS3—systemic scleroderma	7.42e-06	0.00181	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—RHOB—systemic scleroderma	7.37e-06	0.0018	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CSK—systemic scleroderma	7.37e-06	0.0018	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CSK—systemic scleroderma	7.25e-06	0.00177	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—EDN1—systemic scleroderma	7.21e-06	0.00176	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—EDN1—systemic scleroderma	7.21e-06	0.00176	CbGpPWpGaD
Theophylline—HDAC2—Disease—CD247—systemic scleroderma	7.2e-06	0.00176	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HSPG2—systemic scleroderma	7.14e-06	0.00174	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—RHOB—systemic scleroderma	7.09e-06	0.00173	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SMAD7—systemic scleroderma	7.08e-06	0.00173	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—EDN1—systemic scleroderma	7.01e-06	0.00171	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—RHOB—systemic scleroderma	7.01e-06	0.00171	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—EDN1—systemic scleroderma	6.99e-06	0.00171	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HSPG2—systemic scleroderma	6.95e-06	0.0017	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CSK—systemic scleroderma	6.9e-06	0.00169	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—EDN1—systemic scleroderma	6.88e-06	0.00168	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—NOS3—systemic scleroderma	6.76e-06	0.00165	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—EDN1—systemic scleroderma	6.75e-06	0.00165	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CSK—systemic scleroderma	6.71e-06	0.00164	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HSPG2—systemic scleroderma	6.69e-06	0.00163	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—EDN1—systemic scleroderma	6.67e-06	0.00163	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HSPG2—systemic scleroderma	6.61e-06	0.00161	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—EDN1—systemic scleroderma	6.55e-06	0.0016	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—CTGF—systemic scleroderma	6.47e-06	0.00158	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CSK—systemic scleroderma	6.46e-06	0.00158	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CSK—systemic scleroderma	6.38e-06	0.00156	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—EDN1—systemic scleroderma	6.37e-06	0.00156	CbGpPWpGaD
Theophylline—ADORA2A—GPCR ligand binding—CCL2—systemic scleroderma	6.3e-06	0.00154	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	6.28e-06	0.00153	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—EDN1—systemic scleroderma	6.13e-06	0.0015	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—EDN1—systemic scleroderma	6.06e-06	0.00148	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	6.04e-06	0.00147	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—RHOB—systemic scleroderma	5.89e-06	0.00144	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HSPG2—systemic scleroderma	5.55e-06	0.00136	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.53e-06	0.00135	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—RHOB—systemic scleroderma	5.48e-06	0.00134	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—NOS3—systemic scleroderma	5.4e-06	0.00132	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—CCL2—systemic scleroderma	5.4e-06	0.00132	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CSK—systemic scleroderma	5.36e-06	0.00131	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—EDN1—systemic scleroderma	5.21e-06	0.00127	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HSPG2—systemic scleroderma	5.16e-06	0.00126	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CSK—systemic scleroderma	4.99e-06	0.00122	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—CCL2—systemic scleroderma	4.93e-06	0.0012	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—TGFB1—systemic scleroderma	4.91e-06	0.0012	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—CCL2—systemic scleroderma	4.78e-06	0.00117	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—EDN1—systemic scleroderma	4.73e-06	0.00116	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—CCL2—systemic scleroderma	4.7e-06	0.00115	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—EDN1—systemic scleroderma	4.67e-06	0.00114	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.57e-06	0.00112	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	4.5e-06	0.0011	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CCL2—systemic scleroderma	4.47e-06	0.00109	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—TGFB1—systemic scleroderma	4.47e-06	0.00109	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—HSPG2—systemic scleroderma	4.36e-06	0.00107	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CCL2—systemic scleroderma	4.35e-06	0.00106	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EDN1—systemic scleroderma	4.26e-06	0.00104	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.19e-06	0.00102	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CCL2—systemic scleroderma	4.19e-06	0.00102	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CCL2—systemic scleroderma	4.14e-06	0.00101	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EDN1—systemic scleroderma	4.13e-06	0.00101	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EDN1—systemic scleroderma	4.06e-06	0.000992	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EDN1—systemic scleroderma	3.87e-06	0.000945	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	3.85e-06	0.00094	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EDN1—systemic scleroderma	3.76e-06	0.000919	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EDN1—systemic scleroderma	3.62e-06	0.000885	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EDN1—systemic scleroderma	3.58e-06	0.000874	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TGFB1—systemic scleroderma	3.57e-06	0.000873	CbGpPWpGaD
Theophylline—ADA—Metabolism—NOS3—systemic scleroderma	3.55e-06	0.000866	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	3.41e-06	0.000834	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—CTGF—systemic scleroderma	3.31e-06	0.000808	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCL2—systemic scleroderma	3.23e-06	0.00079	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCL2—systemic scleroderma	3.19e-06	0.000779	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EDN1—systemic scleroderma	3.01e-06	0.000735	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.92e-06	0.000712	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCL2—systemic scleroderma	2.91e-06	0.000711	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—HSPG2—systemic scleroderma	2.85e-06	0.000696	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—NOS3—systemic scleroderma	2.84e-06	0.000695	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCL2—systemic scleroderma	2.82e-06	0.00069	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EDN1—systemic scleroderma	2.8e-06	0.000683	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCL2—systemic scleroderma	2.78e-06	0.000678	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—HSPG2—systemic scleroderma	2.69e-06	0.000657	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCL2—systemic scleroderma	2.64e-06	0.000646	CbGpPWpGaD
Theophylline—HDAC2—Disease—NOS3—systemic scleroderma	2.62e-06	0.000639	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—NOS3—systemic scleroderma	2.59e-06	0.000634	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCL2—systemic scleroderma	2.57e-06	0.000628	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—NOS3—systemic scleroderma	2.52e-06	0.000615	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—NOS3—systemic scleroderma	2.48e-06	0.000605	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCL2—systemic scleroderma	2.48e-06	0.000605	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—HSPG2—systemic scleroderma	2.46e-06	0.000602	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCL2—systemic scleroderma	2.45e-06	0.000597	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NOS3—systemic scleroderma	2.36e-06	0.000576	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NOS3—systemic scleroderma	2.29e-06	0.00056	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MMP9—systemic scleroderma	2.28e-06	0.000557	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NOS3—systemic scleroderma	2.21e-06	0.000539	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NOS3—systemic scleroderma	2.18e-06	0.000533	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CTGF—systemic scleroderma	2.16e-06	0.000528	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MMP9—systemic scleroderma	2.08e-06	0.000509	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL2—systemic scleroderma	2.06e-06	0.000502	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CTGF—systemic scleroderma	2.04e-06	0.000498	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HSPG2—systemic scleroderma	2.02e-06	0.000494	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MMP9—systemic scleroderma	2.02e-06	0.000493	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HSPG2—systemic scleroderma	2.01e-06	0.00049	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MMP9—systemic scleroderma	1.99e-06	0.000485	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL2—systemic scleroderma	1.91e-06	0.000467	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MMP9—systemic scleroderma	1.89e-06	0.000462	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TGFB1—systemic scleroderma	1.88e-06	0.000459	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CTGF—systemic scleroderma	1.87e-06	0.000456	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MMP9—systemic scleroderma	1.84e-06	0.000449	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NOS3—systemic scleroderma	1.83e-06	0.000448	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MMP9—systemic scleroderma	1.77e-06	0.000432	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MMP9—systemic scleroderma	1.75e-06	0.000427	CbGpPWpGaD
Theophylline—HDAC2—Disease—TGFB1—systemic scleroderma	1.73e-06	0.000423	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TGFB1—systemic scleroderma	1.72e-06	0.000419	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HSPG2—systemic scleroderma	1.71e-06	0.000419	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NOS3—systemic scleroderma	1.7e-06	0.000416	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TGFB1—systemic scleroderma	1.66e-06	0.000406	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TGFB1—systemic scleroderma	1.64e-06	0.0004	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFB1—systemic scleroderma	1.56e-06	0.000381	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.53e-06	0.000375	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CTGF—systemic scleroderma	1.52e-06	0.000371	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFB1—systemic scleroderma	1.52e-06	0.00037	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—systemic scleroderma	1.47e-06	0.000359	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—systemic scleroderma	1.46e-06	0.000356	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—systemic scleroderma	1.44e-06	0.000352	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—NOS3—systemic scleroderma	1.44e-06	0.000352	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—systemic scleroderma	1.37e-06	0.000334	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HSPG2—systemic scleroderma	1.32e-06	0.000323	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CTGF—systemic scleroderma	1.3e-06	0.000317	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—systemic scleroderma	1.21e-06	0.000296	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—systemic scleroderma	1.13e-06	0.000275	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CTGF—systemic scleroderma	1e-06	0.000245	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NOS3—systemic scleroderma	9.4e-07	0.00023	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NOS3—systemic scleroderma	8.87e-07	0.000217	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NOS3—systemic scleroderma	8.13e-07	0.000199	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NOS3—systemic scleroderma	6.67e-07	0.000163	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NOS3—systemic scleroderma	6.62e-07	0.000162	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NOS3—systemic scleroderma	5.65e-07	0.000138	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NOS3—systemic scleroderma	4.36e-07	0.000107	CbGpPWpGaD
